These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18678433)

  • 41. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed?
    Volk M; Marrero JA
    Gastroenterology; 2008 May; 134(5):1612-4. PubMed ID: 18471530
    [No Abstract]   [Full Text] [Related]  

  • 42. Predictive markers for postsurgical recurrence of hepatocellular carcinoma.
    Gao ZH
    J Surg Oncol; 2005 Dec; 92(4):274-5. PubMed ID: 16299794
    [No Abstract]   [Full Text] [Related]  

  • 43. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
    Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
    J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. To biopsy or not to biopsy?
    Perkins JD
    Liver Transpl; 2006 May; 12(5):885-6. PubMed ID: 16708420
    [No Abstract]   [Full Text] [Related]  

  • 45. Deciphering hepatocellular carcinoma: from bench to bedside and back.
    Goessling W
    Gastroenterology; 2009 Sep; 137(3):786-8. PubMed ID: 19643190
    [No Abstract]   [Full Text] [Related]  

  • 46. [Liver transplantation in metastatic neuroendocrine tumors. Symptom-free intervals and cure possible].
    Ahlman H; Olausson M; Friman S; Herlenius G; Cahlin C; Nilsson O; Jansson S; Wängberg B
    Lakartidningen; 2007 Sep 5-11; 104(36):2519-23. PubMed ID: 17939441
    [No Abstract]   [Full Text] [Related]  

  • 47. Tumour size and differentiation in predicting recurrence of hepatocellular carcinoma after liver transplantation: external validation of a new prognostic score.
    Marelli L; Grasso A; Pleguezuelo M; Martines H; Stigliano R; Dhillon AP; Patch D; Davidson BR; Sharma D; Rolles K; Burroughs AK
    Ann Surg Oncol; 2008 Dec; 15(12):3503-11. PubMed ID: 18777193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New surgical approaches in the treatment of hepatocellular carcinoma].
    Hoffmann K; Schmidt J
    Z Gastroenterol; 2009 Jan; 47(1):61-7. PubMed ID: 19156593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation for hepatocellular carcinoma with intrahepatic lymphatic invasion: case reports.
    Sotiropoulos GC; Molmenti EP; Fouzas I; Sgourakis G; Radtke A; Malagó M; Lang H
    Transplant Proc; 2008 Nov; 40(9):3213-4. PubMed ID: 19010238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiating early and late recurrences after resection of HCC in cirrhotic patients: implications on surveillance, prevention, and treatment strategies.
    Poon RT
    Ann Surg Oncol; 2009 Apr; 16(4):792-4. PubMed ID: 19190964
    [No Abstract]   [Full Text] [Related]  

  • 52. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Analysis of 4q LOH in hepatoid adenocarcinoma, common gastric cancer, and hepatocellular carcinoma].
    Wada T
    Hokkaido Igaku Zasshi; 2004 Sep; 79(5):541-6. PubMed ID: 15540658
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of hepatocellular carcinoma after transplantation and human rights.
    Crippin JS
    Hepatology; 2007 Feb; 45(2):263-5. PubMed ID: 17256762
    [No Abstract]   [Full Text] [Related]  

  • 55. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
    Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
    Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
    Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
    Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of intraoperative homologous blood transfusion on prognosis after liver transplantation for hepatocellular carcinoma.
    Kaido T; Takada Y; Egawa H; Uemoto S
    Hepatogastroenterology; 2009; 56(91-92):808-12. PubMed ID: 19621707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver transplantation for hepatocellular carcinoma: the Hangzhou experience.
    Busuttil RW
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):235-6. PubMed ID: 18522877
    [No Abstract]   [Full Text] [Related]  

  • 60. Gain of GRHL2 is associated with early recurrence of hepatocellular carcinoma.
    Tanaka Y; Kanai F; Tada M; Tateishi R; Sanada M; Nannya Y; Ohta M; Asaoka Y; Seto M; Shiina S; Yoshida H; Kawabe T; Yokosuka O; Ogawa S; Omata M
    J Hepatol; 2008 Nov; 49(5):746-57. PubMed ID: 18752864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.